New research indicates that individuals who discontinue blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds far faster than those who halt traditional lifestyle programs.
Findings released in a prominent medical journal shows that while obese individuals can lose substantial amounts of their total mass while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"Users purchasing these medications should be cognizant of the danger of fast rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to starting mass in about 18 months.
Analyzing Approaches
The analysis, which looked at 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with conventional dieting.
Researchers point out that individuals who lose weight through diet and exercise generally have a more gradual weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Quick Rebound
Experts suggest the mechanism of the drugs explains the accelerated rebound.
GLP-1 drugs imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Artificially providing the hormone levels several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating a significant risk."
A Chronic Disease?
Health authorities suggest the jabs for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Professionals contend that, considering the likelihood of weight regain, the therapy might need to be ongoing.
This view is supported by drug manufacturers, who say that the results "emphasize the chronic character of excess weight," similar to managing conditions like hypertension.
Patient Testimonies
Users who have come off the medication explain a intense return of cravings.
"I experienced something flipping and I was suddenly starving," said an individual.
This difficulty is exacerbated if users have not developed sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Figures suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Use is more common among women than males.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
Ultimately, experts caution that while the jabs are effective tools for shedding pounds, they are not a standalone cure and long-term success likely depends on ongoing lifestyle support.